mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.06 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.06 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
OSU-03012 |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.06 |